SBIR/STTR Research Award

Electro-Mechanical Occlusive Device

Award identifier 098e77897bc678bf934f45fb78ce75e0bca5d0fad9b5b36d386ebea82a75e1a9Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$299,245

Program and phase

SBIR · Phase I

Award year

2007

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
GT UROLOGICAL, LLC
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): GT Urological, LLC has prepared this NIH SBIR Phase I grant application entitled "Electro Mechanical Occlusive Device (EMOD)" to detail goals and activities related to the design and development of a totally implantable, electro-mechanically actuated urethral occlusive device intended to safely and effectively prevent urinary leakage in males and females suffering from Stress Urinary Incontinence (SUI). SUI frequently occurs in males who have undergone surgery to remove their cancerous prostates. Females frequently become incontinent due to child birth injury. EMOD offers significant advantages over existing urinary incontinence treatments that impart a permanent partial obstruction to voiding or require extensive surgery such as bulking agents, urethral slings and hydraulic cuffs. The only commercially available hydraulic cuff, the AMS AUS 800(r) is unable to adjust to accommodate changes in intra-abdominal pressure induced by stressful events and leakage frequently occurs. EMOD advantages include 1) responsiveness to real-time changes in intra-abdominal pressure leading to urinary leakage, 2) a reduction in urethral atrophy and erosion and 3) non-surgical, post- operative adjustability of urethral pressure to accommodate changing degrees of urinary incontinence. Preliminary activities in this proposal include fabrication of a Mico Electo Mechanical Systems (MEMS) Fluidic Pump at the University of Minnesota, Department of Mechanical Engineering. An Electronic Control System with associated firmware, a Urethral Occlusive Cuff and Fluid Capacitor will also be fabricated. Once fabricated, the components will be integrated and debugged using on-bench techniques and ex-vivo porcine bladders. An acute, live animal study will then be performed to display the EMOD's ability to prevent urine leakage in response to simulated stress events. It is GT Urological's intent to perform additional EMOD development beyond the scope of this grant which will lead to EMOD commercialization. Electro Mechanical Occlusive Device (EMOD) Project Narrative The Electro Mechanical Occlusive Device (EMOD) is intended to provide relief to an estimated 13 million US men and women suffering from stress and mixed urinary incontinence. The EMOD is intended to provide functional and surgical advantages over current technologies used for the treatment of stress and mixed urinary incontinence.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.